Skip to content
AkademScholar

Products

For developers

AkademBasesoonDeveloper API
Journal

ESMO Open

ISSN:
2059-7029
0
h-index
0
Citations
16
Works
0.00
2-year mean citedness

Trust signals

1 of 3 signals present

Independent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.

  • DOAJ
    No data
    doaj.org
  • OAK list
    No data
    OAK
  • Valid ISSN
    Present
    ISSN

This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.

Trends over time

Performance over time

Citation overview

Publications (bars) and citations (line) by year

  • Publications
  • Citations
03581001201820232024202520262018: Publications 1, Citations 02023: Publications 2, Citations 02024: Publications 8, Citations 02025: Publications 4, Citations 02026: Publications 1, Citations 0

Publication history

035810201820232024202520262018: Publications 12023: Publications 22024: Publications 82025: Publications 42026: Publications 1

h-index evolution

Cumulative h-index by year

01201820232024202520262018: h-index 02023: h-index 02024: h-index 02025: h-index 02026: h-index 0

Most-cited works

  1. PO-291 The disbalance of the basic cytokines of the immune system in patients with ovarian cancer on the background of immunotherapy20180 citations
  2. 10P Neoadjuvant chemotherapy with bevacizumab for IIb stage cervical cancer: Is it time to rethink standard of care?20230 citations
  3. 19P Neoadjuvant chemotherapy followed by radical surgery vs chemoradiotherapy in patients with cervical cancer (stage IIB, FIGO 2018)20230 citations
  4. 39P The possibility of predicting the effectiveness of treatment of soft tissue sarcomas on the basis of the properties of their immunologic microenvironment20240 citations
  5. 35P Beyond microsatellite testing: Tumor mutational burden, should it be routine in patients with GI cancers?20240 citations
  6. 95P The study of immune microenvironment subpopulations in soft tissue sarcomas20240 citations
  7. 111P Oncologic outcomes of the pelvic bone tumors20240 citations
  8. 153P The preoperative treatment of patients with giant cell tumors of limb bones by denosumab therapy20240 citations
  9. 68P The effectiveness of treatment of ascites due to recurrence of platinum-refractory ovarian cancer using metronomic chemotherapy20240 citations
  10. 30P Cemiplimab in treatment of metastatic and recurrent cervical cancer20240 citations
View in AkademIndex →